Docebo (DCBO) Common Equity (2020 - 2026)

Docebo (DCBO) has reported Common Equity for 7 consecutive years, with -$616000.0 the latest figure, recorded in Q1 2026.

• Quarterly Common Equity fell 101.17% year-over-year to -$616000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$616000.0 (down 101.17% YoY) and the FY2025 annual result came in at $74.1 million, up 28.27% from the prior year.
• Common Equity declined to -$616000.0 in Q1 2026 per DCBO's latest filing, from $74.1 million in the prior quarter.
• Over the last five years, Common Equity for DCBO reached as high as $195.2 million in Q1 2023 and fell as low as -$616000.0 in Q1 2026.
• A 5-year average of $103.0 million and a median of $66.9 million in 2024 frame the typical range for Common Equity.
• Annual changes were most pronounced in 2025 — Common Equity rose 28.27% — and 2026, when it tumbled 101.17%.
• Year by year, Common Equity stood at $192.2 million in 2022, then plunged by 73.61% to $50.7 million in 2023, then increased by 13.88% to $57.8 million in 2024, then grew by 28.27% to $74.1 million in 2025, then plunged by 100.83% to -$616000.0 in 2026.
• According to Business Quant data, Common Equity over the past three periods registered -$616000.0, $74.1 million, and $34.7 million for Q1 2026, Q4 2025, and Q2 2025 respectively.